HLB will establish the right direction of management by enacting the Corporate Governance Charter,
share values with customers, shareholders, executives, and employees, and become a more trusted company.
Category | 2020 | 2021 | 2022 |
Total | B | C | B |
Category | 2020 | 2021 | 2022 |
Total | C | B | C |
Environment | D | B | C |
Society | B | B+ | B |
Governance | C | B | D |
Recommendation | Acceptance | Note |
Introduction of Corporate Governance Charter | ◯ | |
Introduction of ethics regulations for executives and employees | ◯ | |
Composition of Board of Directors (majority of Independent directors) | X | 6 Internal, 3 Independent |
Separation between the CEO and the chairman of the board of directors | X | |
Disclosure of the details of activities of the board of directors, attendance rate, and pros and cons of major agenda items | ◯ | |
Composition of Independent director candidate recommendation committee | ◯ | |
Disclosure of Governance Ratings | ◯ | |
Formation of an audit committee (all Independent directors) | ◯ | |
Introduction of regulations on the roles and operating procedures of the board of directors and various committees | ◯ | |
Director's liability insurance at the company's expense | ◯ | Directors & Officers Liability (annual) |
Evaluation of the activities of the board of directors | ◯ | |
Maintaining independence of external auditors | ◯ | |
Certification of accuracy and completeness of financial reporting by the Representative Director and Financial Officer | ◯ | |
Description of differences from the criteria | ◯ | Website |
(unit: KRW)
Sort | 2020 | 2021 | 2022 | |
Environmental law |
Penalty | - | - | - |
No. of violations | - | - | - | |
Unfair transaction (including corruption and bribery) | Penalty | - | - | - |
No. of violations | - | - | - | |
Regulations related to domestic marketing activities | Penalty | - | - | - |
No. of violations | - | - | - | |
Customer information protection | Penalty | - | - | - |
No. of violations | - | - | - | |
Product information provision notice | Penalty | - | - | - |
No. of violations | - | - | - | |
Regulations related to counterfeit products | Penalty | - | - | - |
No. of violations | - | - | - | |
Clinical trial regulations in developing countries | Penalty | - | - | - |
No. of violations | - | - | - | |
Regulations of the Act on the Health and Safety Impact of Products and Services and No. of cases in violation of autonomous regulations |
Penalty | - | - | - |
No. of violations | - | - | - |